Search

everythinglearnresearchcommunity

for

Search:↓

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

Lhx2 is a crucial regulator of the Sonic Hedgehog signaling in early mouse retinal development.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Lizards can regrow their tail scales with the same structure, distribution, and gender-specific features as the original ones, and this unique ability is not seen in adult mammals.

Msx-2 gene removal speeds up skin wound healing in mice.

CXCR2 in skin cells promotes tumor growth.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Lack of TrkC receptor delays hair follicle development.

Cats infested with Lynxacarus radovskyi can lose hair without inflammation, treatable with selamectin.

A specific gene mutation causes different hair defects in Indian monilethrix families.

Lymphotoxin-β is crucial for proper skin development in embryos.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

A new MTX2 gene mutation caused a severe genetic disorder in a young Chinese girl.

A new genetic mutation causes severe Leydig cell hypoplasia, affecting sexual development.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

The 736T>A mutation in the LIPH gene is common in Japanese people with autosomal recessive woolly hair.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Tick-bite alopecia can be identified by a bite-centered mark and treated with topical steroids, while SENLAT needs doxycycline.

Fipronil effectively treats Lynxacarus radovskyi in outdoor cats.

Females are more prone to lupus and arthritis due to X chromosome factors.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

New RIPK4 gene mutations were found to cause a type of skin and limb birth defect.

Early diagnosis and a multidisciplinary approach are crucial for children with Trichothiodystrophy and hidden learning disorders.

Botulinum neurotoxin A is effective and safe for treating various conditions, but more clinical trials are needed to fully assess its benefits and risks.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.